About this trial

The ICD Registry™ is a nationwide quality program that helps participating hospitals measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds). The ICD Registry captures the characteristics, treatments, and outcomes of patients receiving (ICDs). Patient-level data is submitted by participating hospitals on a quarterly basis to the American College of Cardiology Foundation's (ACCF) National Cardiovascular Data Registry (NCDR) which then produces an Outcomes Report of the hospital's data, with comparison to both a volume peer group (number of ICD patients submitted annually) and the entire ICD registry data set.

Eligibility criteria

Qualifiers

All patients who receive an ICD/CRT-D (initial or generator change) for primary or secondary prevention purposes.

All patients with an ICD/CRT-D undergoing a Lead Only procedure.

U.S. populations must submit all patients who receive an ICD/CRT-D (initial or generator change) for primary prevention purposes who are insured by Medicare.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,750 Participants
are grouped into 1 trial group

Locations

1
American College of Cardiology/National Cardiovascular Data Registry (NCDR)20037, Washington D.C.District of Columbia, United States

Sponsors and collaborators

American College of Cardiology

Lead sponsor